These benefits, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the principle of targeting ACKR3 as a novel method to modulate the opioid program, which could open up new therapeutic avenues for opioid-related disorders. (2) The health practitioner has https://toddr627jaq3.jasperwiki.com/user